Cognition and synaptic plasticity in diabetes mellitus

Trends in Neurosciences

Volumn 23, Issue 11, 2000, Pages 542-549

  Gispen, Willem Hendrik ^a   Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; INSULIN; PROTEIN KINASE; RECEPTOR SUBTYPE;

AGED; AGING; ANIMAL MODEL; BRAIN DISEASE; CHRONIC DISEASE; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DIABETIC NEUROPATHY; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING; METABOLIC DISORDER; MORPHOLOGY; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK; SECOND MESSENGER; SPATIAL MEMORY; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

EID: 0034333018     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01656-8     Document Type: Article

References (76)

1. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973 (Pt 1)
2. The impact of diabetes on the CNS
3. Cerebral function in diabetes mellitus
4. Stroke in the diabetic patient
5. Hypoglycemia
6. Neurobehavioral complications of type I diabetes. Examination of possible risk factors
7. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies
8. Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: a complication of diabetes or a consequence of treatment?
9. Type 2 diabetes mellitus, cognitive impairment and dementia
10. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men
11. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function
12. Diabetes mellitus and the risk of dementia: The Rotterdam Study
13. Electrophysiological alterations of the central nervous system in diabetes mellitus
14. MRI of the brain in diabetes mellitus
15. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home
16. Diabetes mellitus: stress, neurochemistry and behavior
17. Stress and behavior in streptozotocin diabetic rats: biochemical correlates of passive avoidance learning
18. Characteristics of learning and memory in streptozocin-induced diabetic mice
19. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade
20. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats
21. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing
22. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment
23. Electrophysiological study of dorsal column function in streptozotocin-induced diabetic rats: comparison with 2, 5-hexanedione intoxication
24. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats: course of development and effects of insulin treatment
25. Peripheral, but not central, nervous system abnormalities are reversed by pancreatic islet transplantation in diabetic Lewis rats
26. A synaptic model of memory: long-term potentiation in the hippocampus
27. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats
28. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression
29. Diabetes mellitus preserves synaptic plasticity in hippocampal slices from middle-aged rats
30. Short-term synaptic plasticity
31. Synaptic activity modulates the induction of bidirectional synaptic changes in adult mouse hippocampus
32. Different voltage-dependent thresholds for inducing long-term depression and long-term potentiation in the rat visual cortex
33. Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes
34. Reduced adenosine uptake accelerates ischaemic block of population spikes in hippocampal slices from streptozotocin-treated diabetic rats
35. Endogenous adenosine modulates long-term potentiation in the hippocampus
36. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats
37. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats
38. Genetic enhancement of learning and memory in mice
39. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes
40. The antioxidative potential of cerebral microvessels in experimental diabetes mellitus
41. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain
42. Excessive non enzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats
43. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus
44. Diabetes mellitus: a disease of abnormal cellular calcium metabolism?
45. Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats
46. Cerebrovascular disorders in patients with diabetes mellitus
47. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and non-insulin-dependent diabetes mellitus
48. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications
49. Diabetic neuropathy, nerve growth factor and other neurotrophic factors
50. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications
51. Oxidative stress and antioxidant treatment in diabetic neuropathy
52. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy
53. Sustained recovery of Na(1)-K(1)-ATPase activity in sciatic nerve of diabetic mice by admini-stration of H7 or calphostin C, inhibitors of PKC
54. Impact of diabetes on CNS: role of signal transduction cascade
55. Glycation products and the pathogenesis of diabetic complications
56. Antioxidant defense systems in the brains of type II diabetic mice
57. Radical AGEing in Alzheimer's disease
58. The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy
59. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone
60. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
61. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons
62. Protein glycation and oxidative stress in diabetes mellitus and ageing
63. Differential degeneration of the cerebral microvasculature in Alzheimer's disease
64. Can disturbed brain microcirculation cause Alzheimer's disease?
65. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise
66. Calcium hypothesis of Alzheimer's disease and brain aging
67. Insulin receptors are widely distributed in the central nervous system of the rat
68. Glucose intolerance, cognitive impairment and Alzheimer's disease
69. Insulin and cognitive function in an elderly population - The Rotterdam Study
70. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype
71. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease
72. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis
73. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
74. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus
75. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes